NFKB1 and Hypertension: An in vivo study offered compelling evidence that inhibition of NF-κB activation contributes to the regression of LVH in 2 animal models of hypertension, including spontaneously hypertensive rats and normotensive Wistar Kyoto rats exposed to chronic administration of phenylephrine [19].